Overview
Location
United States, California, Palo Alto
Employees
11-50
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 23, 2007 | AstraZeneca ups the biotech ante | Now that AstraZeneca has made the bold — or impulsive — decision to snap up MedImmune for $15.6 billion in cash, one big question is whether the U.K. pharmaceutical giant has kicked Big Pharma’s appetite for biotech acquisitions into high g... |
| Dec 27, 2006 | Failure of biotech drug company, Telik, is striking | Telik, the Palo Alto biotech company, is a striking example of the sort of monstrous results our ecosystem in Silicon Valley can produce. Just three years ago, Telik was hailed as one of the country’s most promising biotech stocks. But Tues... |
Reviews 0
FAQ about Telik
What has the press written about Telik?
Parsers VC has collected 3 articles mentioning Telik, among them “AstraZeneca ups the biotech ante” (Apr 23, 2007) and “Failure of biotech drug company, Telik, is striking” (Dec 27, 2006).
Is Telik still active?
Yes, Telik is active; its latest activity on Parsers VC dates from Jun 7, 2007.